1 No-Brainer Stock to Buy on the Dip

Core Viewpoint - Intuitive Surgical is facing challenges in the current market, but patient investors may find opportunities as the stock has recently dipped due to weak guidance for future growth [1][3]. Financial Performance - In Q4 2025, Intuitive Surgical reported a revenue increase of 19% year-over-year, reaching $2.87 billion, with a 17% rise in da Vinci procedure volume and earnings per share of $2.21, up 17.6% year-over-year [2]. - The company anticipates da Vinci procedure volume growth of 13% to 15% for fiscal 2026, a decrease from 18% in 2025, which is a critical factor for revenue growth [3]. Market Position and Valuation - Intuitive Surgical is currently trading at 54 times forward earnings, significantly higher than the healthcare sector average of 18.6, indicating that the stock is priced for perfection [4]. - The company has a market capitalization of $179 billion, with a current stock price of $504.22, and a gross margin of 70.56% [6]. Long-term Prospects - Despite potential short-term volatility, Intuitive Surgical is positioned well for long-term growth due to the underpenetrated robotic-assisted surgery market and demographic trends such as an aging population [6][9]. - The company benefits from high switching costs and significant barriers to entry, along with extensive real-world data supporting improved patient outcomes [7]. Valuation Considerations - When considering expected growth, Intuitive Surgical's price/earnings-to-growth multiple is 3.2, which, while above the typical reasonable range, is not excessively high given the company's competitive advantages [8].